Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock
Series A
Preferred Stock
Series B
Preferred Stock
Convertible preferred stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at beginning of period at Dec. 31, 2022 $ 49     $ 86 $ 1,306,271   $ (1,182,392) $ 124,014
Balance at beginning of period (in shares) at Dec. 31, 2022 984,000 2,000 5,000 11,454,000        
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock related to 401(k) contribution         123     123
Issuance of common stock related to 401(k) contribution (in shares)       7,000        
Stock-based compensation expense         1,570     1,570
Preferred stock dividends         (1,368)     (1,368)
Net income (loss)             (9,813) (9,813)
Balance at end of period at Mar. 31, 2023 $ 49     $ 86 1,306,596   (1,192,205) 114,526
Balance at end of period (in shares) at Mar. 31, 2023 984,000 2,000 5,000 11,461,000        
Balance at beginning of period at Dec. 31, 2022 $ 49     $ 86 1,306,271   (1,182,392) 124,014
Balance at beginning of period (in shares) at Dec. 31, 2022 984,000 2,000 5,000 11,454,000        
Increase (Decrease) in Stockholders' Equity                
Net income (loss)               (20,722)
Balance at end of period at Sep. 30, 2023 $ 49     $ 86 1,308,943   (1,203,114) 105,964
Balance at end of period (in shares) at Sep. 30, 2023 984,000 2,000 5,000 11,472,000        
Balance at beginning of period at Dec. 31, 2022 $ 49     $ 86 1,306,271   (1,182,392) 124,014
Balance at beginning of period (in shares) at Dec. 31, 2022 984,000 2,000 5,000 11,454,000        
Balance at end of period at Dec. 31, 2023 $ 49     $ 86 1,311,809   (1,223,223) 88,721
Balance at end of period (in shares) at Dec. 31, 2023 984,000 2,000 5,000 11,495,000        
Balance at beginning of period at Mar. 31, 2023 $ 49     $ 86 1,306,596   (1,192,205) 114,526
Balance at beginning of period (in shares) at Mar. 31, 2023 984,000 2,000 5,000 11,461,000        
Increase (Decrease) in Stockholders' Equity                
Exercise of stock options         153     153
Exercise of stock options (in shares)       8,000        
Issuance of common stock related to ESPP         50     50
Issuance of common stock related to ESPP (in shares)       3,000        
Stock-based compensation expense         2,163     2,163
Preferred stock dividends         (1,368)     (1,368)
Net income (loss)             (5,400) (5,400)
Balance at end of period at Jun. 30, 2023 $ 49     $ 86 1,307,594   (1,197,605) 110,124
Balance at end of period (in shares) at Jun. 30, 2023 984,000 2,000 5,000 11,472,000        
Increase (Decrease) in Stockholders' Equity                
Stock-based compensation expense         2,717     2,717
Preferred stock dividends         (1,368)     (1,368)
Net income (loss)             (5,509) (5,509)
Balance at end of period at Sep. 30, 2023 $ 49     $ 86 1,308,943   (1,203,114) 105,964
Balance at end of period (in shares) at Sep. 30, 2023 984,000 2,000 5,000 11,472,000        
Balance at beginning of period at Dec. 31, 2023 $ 49     $ 86 1,311,809   (1,223,223) 88,721
Balance at beginning of period (in shares) at Dec. 31, 2023 984,000 2,000 5,000 11,495,000        
Increase (Decrease) in Stockholders' Equity                
Exercise of stock options       $ 1 621     622
Exercise of stock options (in shares)       135,000        
Issuance of common stock related to 401(k) contribution         118     118
Issuance of common stock related to 401(k) contribution (in shares)       7,000        
Stock-based compensation expense         2,856     2,856
Preferred stock dividends         (1,368)     (1,368)
Repurchase of common stock             (13) (13)
Repurchase of common stock (in shares)       (1,000)        
Net income (loss)             (8,595) (8,595)
Balance at end of period at Mar. 31, 2024 $ 49     $ 87 1,314,036   (1,231,831) 82,341
Balance at end of period (in shares) at Mar. 31, 2024 984,000 2,000 5,000 11,636,000        
Balance at beginning of period at Dec. 31, 2023 $ 49     $ 86 1,311,809   (1,223,223) $ 88,721
Balance at beginning of period (in shares) at Dec. 31, 2023 984,000 2,000 5,000 11,495,000        
Increase (Decrease) in Stockholders' Equity                
Exercise of stock options (in shares)               246,599
Repurchase of common stock               $ (13)
Repurchase of common stock (in shares)               (660)
Net unrealized gain on available-for-sale debt securities               $ 104
Net income (loss)               (9,853)
Balance at end of period at Sep. 30, 2024 $ 49     $ 88 1,317,657 $ 104 (1,233,089) 84,809
Balance at end of period (in shares) at Sep. 30, 2024 984,000 2,000 5,000 11,755,000        
Balance at beginning of period at Mar. 31, 2024 $ 49     $ 87 1,314,036   (1,231,831) 82,341
Balance at beginning of period (in shares) at Mar. 31, 2024 984,000 2,000 5,000 11,636,000        
Increase (Decrease) in Stockholders' Equity                
Exercise of stock options         250     250
Exercise of stock options (in shares)       15,000        
Issuance of common stock related to ESPP         95     95
Issuance of common stock related to ESPP (in shares)       7,000        
Stock-based compensation expense         2,690     2,690
Preferred stock dividends         (1,368)     (1,368)
Net income (loss)             15,985 15,985
Balance at end of period at Jun. 30, 2024 $ 49     $ 87 1,315,703   (1,215,846) 99,993
Balance at end of period (in shares) at Jun. 30, 2024 984,000 2,000 5,000 11,658,000        
Increase (Decrease) in Stockholders' Equity                
Exercise of stock options       $ 1 732     733
Exercise of stock options (in shares)       97,000        
Stock-based compensation expense         2,590     2,590
Preferred stock dividends         (1,368)     $ (1,368)
Repurchase of common stock (in shares)               0
Net unrealized gain on available-for-sale debt securities           104   $ 104
Net income (loss)             (17,243) (17,243)
Balance at end of period at Sep. 30, 2024 $ 49     $ 88 $ 1,317,657 $ 104 $ (1,233,089) $ 84,809
Balance at end of period (in shares) at Sep. 30, 2024 984,000 2,000 5,000 11,755,000